Metastatic Merkel Cell Carcinoma: Insights on the Clinical Application of Immune Checkpoint Inhibitors

This multifaceted program which includes a module interactive toxicity management algorithm tool summary resource guide and expert commentaries equips clinicians with evidence-based insights on how to incorporate immune checkpoint inhibitors into clinical management of patients with metastatic Merkel cell carcinoma.

Share

Program Content

Activities

Immune Checkpoint Inhibitors
Immune Checkpoint Inhibitors: A New Hope for Patients With Merkel Cell Carcinoma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 30, 2016

Expires: November 29, 2017

Metastatic MCC Immunotherapy
Rapid Response in a Patient With Bulky Liver Metastases From Merkel Cell Carcinoma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: February 27, 2017

Expires: February 26, 2018

Avelumab for MCC
Avelumab: A New Treatment Paradigm for Metastatic Merkel Cell Carcinoma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: May 19, 2017

Expires: May 18, 2018

MCC: T-Cell Therapy
T-Cell Therapy Plus Avelumab: A New Approach in Merkel Cell Carcinoma
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: August 09, 2017

Expires: August 08, 2018

Activities

Downloadable Slideset
Metastatic Merkel Cell Carcinoma: Insights on the Clinical Application of Immune Checkpoint Inhibitors
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 22, 2017

Expires: February 21, 2018

Activities

Immunotherapy for MCC
Clinician’s Guide: Immunotherapy for Metastatic Merkel Cell Carcinoma
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: March 06, 2017

Expires: March 05, 2018

Faculty

cover img faculity

Shailender Bhatia, MD

Associate Professor
Division of Medical Oncology
Department of Medicine
University of Washington
Attending Physician
Seattle Cancer Care Alliance
Fred Hutchinson Cancer Research Center
Seattle, Washington

cover img faculity

Howard L. Kaufman, MD

Associate Director for Clinical Sciences
Chief Surgical Officer

Department of Surgical Oncology
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey

cover img faculity

Paul Nghiem, MD

Professor and Head
Division of Dermatology
Department of Medicine
University of Washington
Seattle, Washington

Provided by

ProCE Banner

Supporters

This activity is supported by an educational grant from

Merck KGaA

Pfizer, Inc.